Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.58 |
| ▸ | ACHE | P22303 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | CA1 | P00915 | 5/20 | 0.52 |
| ▸ | CA2 | P00918 | 5/20 | 0.52 |
| ▸ | CA9 | Q16790 | 2/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA3 | P07451 | 1/20 | 0.52 |
| ▸ | CA6 | P23280 | 1/20 | 0.52 |
| ▸ | CA5A | P35218 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.52 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | MMP1 | P03956 | 1/20 | 0.46 |
| ▸ | MMP2 | P08253 | 1/20 | 0.46 |
| ▸ | MMP9 | P14780 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6543723 | 0.88 | CES2 (0.56) | GAAACHETDP1CA1CA2 | |
| P-Xylene SCHEMBL9407456 | 0.87 | GAA (0.52) | GAAACHETDP1CA1CA2 | |
| SCHEMBL25207548 | 0.86 | ALDH1A1 (0.68) | GAAACHETDP1CA1CA2 | |
| SCHEMBL27451540 | 0.86 | GAA (0.46) | GAAACHETDP1CA1CA2 | |
| SCHEMBL9015590 | 0.86 | ACHE (0.68) | GAAACHETDP1CA1CA2 | |
| SCHEMBL1150488 | 0.86 | ACHE (0.68) | GAAACHECA1CA2CA9 | |
| Toluene SCHEMBL14976964 | 0.84 | ALOX12 (0.65) | GAAACHETDP1CA1CA2 | |
| Toluene SCHEMBL2874261 | 0.84 | ALOX12 (0.65) | GAAACHETDP1CA1CA2 | |
| Toluene SCHEMBL53563 | 0.84 | ALOX12 (0.65) | GAAACHETDP1CA1CA2 | |
| Toluene SCHEMBL28783164 | 0.84 | ALOX12 (0.65) | GAAACHETDP1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109516987-B | Preparation method of avibactam intermediate | 江西富祥药业股份有限公司 | 2020-07-24 | — | — | CN | claimed |
| CN-108473450-A | The preparation method of 1,1,3- trioxy- -1,2- benzothiazole -6- formamides | 阿达玛阿甘股份有限公司 | 2018-08-31 | — | — | CN | claimed |
| CN-102993435-B | Star copolymer of aniline oligomer and polyethylene glycol and preparation method thereof | UNIV BEIHANG | 2014-08-27 | — | — | CN | claimed |
| CN-102993435-A | Star copolymer of aniline oligomer and polyethylene glycol and preparation method thereof | UNIV BEIHANG | 2013-03-27 | — | — | CN | claimed |
| US-12623478-B2 | Thermosensitive recording layer forming liquid, thermosensitive recording medium and production method thereof, and image recording method | RICOH COMPANY, LTD. (JP) | 2026-05-12 | — | — | US | disclosed |
| US-20240181797-A1 | THERMOSENSITIVE RECORDING LAYER FORMING LIQUID, THERMOSENSITIVE RECORDING MEDIUM AND PRODUCTION METHOD THEREOF, AND IMAGE RECORDING METHOD | RICOH COMPANY, LTD. (JP) | 2024-06-06 | — | — | US | disclosed |
| EP-4313612-A1 | THERMOSENSITIVE RECORDING LAYER FORMING LIQUID, THERMOSENSITIVE RECORDING MEDIUM AND PRODUCTION METHOD THEREOF, AND IMAGE RECORDING METHOD | Ricoh Company, Ltd. (JP) | 2024-02-07 | — | — | EP | disclosed |
| CN-117083182-A | Thermosensitive recording layer forming liquid, thermosensitive recording medium, production method thereof, and image recording method | 株式会社理光 | 2023-11-17 | — | — | CN | disclosed |
| CN-115368280-A | Preparation method and application of novel thermosensitive color developing agent | 康爱特维迅（蓬莱）化学有限公司 | 2022-11-22 | — | — | CN | disclosed |
| WO-2022202154-A1 | THERMOSENSITIVE RECORDING LAYER FORMING LIQUID, THERMOSENSITIVE RECORDING MEDIUM AND PRODUCTION METHOD THEREOF, AND IMAGE RECORDING METHOD | RICOH COMPANY, LTD. (JP) | 2022-09-29 | — | — | WO | disclosed |
| WO-2022145400-A1 | COLOR DEVELOPER, HEAT-SENSITIVE RECORDING MATERIAL, AND COATING MATERIAL FOR HEAT-SENSITIVE RECORDING LAYERS | 三光株式会社 | 2022-07-07 | — | — | WO | disclosed |
| CN-111032626-B | N, N' -diaryl urea derivative, process for producing the same, and thermosensitive recording material using the same | 三光株式会社 | 2022-05-17 | — | — | CN | disclosed |
| CN-1751044-A | Sulfonamide substituted xanthine derivatives for use as PEPCK inhibitors | HOFFMANN LA ROCHE (CH) | 2006-03-22 | — | — | CN | disclosed |
| CN-1639158-A | Thiazole derivatives as NPY receptor antagonists | HOFFMANN LA ROCHE (CH) | 2005-07-13 | — | — | CN | disclosed |
| EP-1501807-A1 | SULFONYLQUINOXALONE ACETAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ ANTAGONISTS | Elan Pharmaceuticals, Inc. (US) | 2005-02-02 | — | — | EP | disclosed |
| US-20040147520-A1 | Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists | ELAN PHARMACEUTICALS, INC. | 2004-07-29 | — | — | US | disclosed |
| US-20040147519-A1 | Sulfonylquinoxalone acetamide derivatives as bradykinin antagonists | ELAN PHARMACEUTICALS, INC. | 2004-07-29 | — | — | US | disclosed |
| WO-2003093245-A1 | SULFONYLQUINOXALONE ACETAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ ANTAGONISTS | ELAN PHARMACEUTICALS, INC. (US) | 2003-11-13 | — | — | WO | disclosed |
| CN-1228765-A | New amidino derivatives and their use as thrombin inhibitors | ASTRA AB (SE) | 1999-09-15 | — | — | CN | disclosed |
| CN-1162596-A | Antiarrhythmic Agents | AMERICAN CYANAMID CO (US) | 1997-10-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040147519-A1 | Sulfonylquinoxalone acetamide derivatives as bradykinin antagonists | BDKRB2, BDKRB1, HRH2 | GAA 3263/4885ACHE 1914/4885TDP1 4539/4885 |
| US-20040147520-A1 | Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists | BDKRB2, BDKRB1, PDXK | GAA 2527/4885ACHE 1863/4885TDP1 4513/4885 |
| US-12623478-B2 | Thermosensitive recording layer forming liquid, thermosensitive recording medium and production method thereof, and image recording method | TRPA1, ASIC1, LRBA | GAA 3624/4885ACHE 2468/4885TDP1 2624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.